Literature DB >> 15557376

In vivo cardiac gene transfer of Kv4.3 abrogates the hypertrophic response in rats after aortic stenosis.

Djamel Lebeche1, Roger Kaprielian, Federica del Monte, Gordon Tomaselli, Judith K Gwathmey, Arnold Schwartz, Roger J Hajjar.   

Abstract

BACKGROUND: Prolongation of the action potential duration (APD) and decreased transient outward K+ current (I(to)) have been consistently observed in cardiac hypertrophy. The relation between electrical remodeling and cardiac hypertrophy in vivo is unknown. METHODS AND
RESULTS: We studied rat hearts subjected to pressure overload by surgical ascending aortic stenosis (AS) and simultaneously infected these hearts with an adenovirus carrying either the Kv4.3 gene (Ad.Kv4.3) or the beta-galactosidase gene (Ad.beta-gal). I(to) density was reduced and APD50 was prolonged (P<0.05) in AS rats compared with sham rats. Kv4.2 and Kv4.3 expressions were decreased by 58% and 51%, respectively (P<0.05). AS rats infected with Ad.beta-gal developed cardiac hypertrophy compared with sham rats, as assessed by cellular capacitance and heart weight-body weight ratio. Associated with the development of cardiac hypertrophy, the expression of calcineurin and its downstream transcription factor nuclear factor of activated T cells (NFAT) c1 was persistently increased by 47% and 36%, respectively (P<0.05) in AS myocytes infected with Ad.beta-gal compared with sham myocytes. In vivo gene transfer of Kv4.3 in AS rats was shown to increase Kv4.3 expression, increase I(to) density, and shorten APD50 by 1.6-fold, 5.3-fold, and 3.6-fold, respectively (P<0.05). Furthermore, AS rats infected with Ad.Kv4.3 showed significant reductions in calcineurin and NFAT expression. (P<0.05).
CONCLUSIONS: Downregulation of I(to), APD prolongation, and cardiac hypertrophy occur early after AS, and in vivo gene transfer of Kv4.3 can restore these electrical parameters and abrogate the hypertrophic response via the calcineurin pathway.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15557376     DOI: 10.1161/01.CIR.0000148176.33730.3F

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  23 in total

Review 1.  The potential role of Kv4.3 K+ channel in heart hypertrophy.

Authors:  Rong Huo; Yue Sheng; Wen-Ting Guo; De-Li Dong
Journal:  Channels (Austin)       Date:  2014       Impact factor: 2.581

Review 2.  Gene therapies for arrhythmias in heart failure.

Authors:  Fadi G Akar; Roger J Hajjar
Journal:  Pflugers Arch       Date:  2014-02-26       Impact factor: 3.657

Review 3.  Transient outward potassium channel: a heart failure mediator.

Authors:  Qianwen He; Ying Feng; Yanggan Wang
Journal:  Heart Fail Rev       Date:  2015-05       Impact factor: 4.214

4.  Kv4.3 expression abrogates and reverses norepinephrine-induced myocyte hypertrophy by CaMKII inhibition.

Authors:  Yanggan Wang; Thitima Keskanokwong; Jun Cheng
Journal:  J Mol Cell Cardiol       Date:  2018-11-18       Impact factor: 5.000

Review 5.  Calcineurin-dependent ion channel regulation in heart.

Authors:  Yanggan Wang; Samvit Tandan; Joseph A Hill
Journal:  Trends Cardiovasc Med       Date:  2013-07-01       Impact factor: 6.677

6.  P2X purinergic receptor-mediated ionic current in cardiac myocytes of calsequestrin model of cardiomyopathy: implications for the treatment of heart failure.

Authors:  Jian-Bing Shen; Chunxia Cronin; Dmitry Sonin; Bhalchandra V Joshi; Maria Gongora Nieto; David Harrison; Kenneth A Jacobson; Bruce T Liang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-10-13       Impact factor: 4.733

7.  Regional and tissue specific transcript signatures of ion channel genes in the non-diseased human heart.

Authors:  Nathalie Gaborit; Sabrina Le Bouter; Viktoria Szuts; Andras Varro; Denis Escande; Stanley Nattel; Sophie Demolombe
Journal:  J Physiol       Date:  2007-05-03       Impact factor: 5.182

8.  Ventricular arrhythmias after left ventricular assist device implantation.

Authors:  Marwan Refaat; Elie Chemaly; Djamel Lebeche; Judith K Gwathmey; Roger J Hajjar
Journal:  Pacing Clin Electrophysiol       Date:  2008-10       Impact factor: 1.976

9.  KChIP2 attenuates cardiac hypertrophy through regulation of Ito and intracellular calcium signaling.

Authors:  Hongwei Jin; Lahouaria Hadri; Julieta Palomeque; Charlotte Morel; Ioannis Karakikes; Roger Kaprielian; Roger Hajjar; Djamel Lebeche
Journal:  J Mol Cell Cardiol       Date:  2010-01-04       Impact factor: 5.000

10.  Curcumin prevents and reverses murine cardiac hypertrophy.

Authors:  Hong-Liang Li; Chen Liu; Geoffrey de Couto; Maral Ouzounian; Mei Sun; Ai-Bing Wang; Yue Huang; Cheng-Wei He; Yu Shi; Xin Chen; Mai P Nghiem; Youan Liu; Manyin Chen; Fayez Dawood; Masahiro Fukuoka; Yuichiro Maekawa; Liyong Zhang; Andrew Leask; Asish K Ghosh; Lorrie A Kirshenbaum; Peter P Liu
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.